Elisabetta Cerudelli

Elisabetta Cerudelli

Auto-generated profile, based on publicly available information

Elisabetta Cerudelli

Nuclear Medicine, Università & Spedali Civili, Brescia, Italy (L.C., E.C.).

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
Domenico AlbanoDomenico Albano
Domenico Albano
GTGiorgio Treglia
Giorgio Treglia
MGMaria Gazzilli
Maria Gazzilli
ECElisabetta Cerudelli
Elisabetta Cerudelli
RGRaffaele Giubbini
Raffaele Giubbini
FBFrancesco Bertagna
Francesco Bertagna

1 October 2023 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
RWR. Glenn Wells
R. Glenn Wells
FBFrank Bengel
Frank Bengel
LCLuca Camoni
Luca Camoni
ECElisabetta Cerudelli
Elisabetta Cerudelli
SCSarah G. Cuddy-Walsh
Sarah G. Cuddy-Walsh
TRTerrence D. Ruddy
Terrence D. Ruddy
Background: Single-center studies have shown that single photon emission computed tomography myocardial blood flow (MBF) measurement is accurate compared with MBF measured with microspheres in a porcine model, positron emission tomography, and angiography. Clinical implementation requires consistency across multiple sites. The study goal is to determine the intersite processing repeatability of single photon emission computed tomography MBF and the additional camera time required. Methods: Five sites (Canada, Italy, Japan, Germany, and Singapore) each acquired 25 to 35 MBF studies at rest and with pharmacological stress using technetium-99m-tetrofosmin on a pinhole-collimated cadmium-zinc-telluride–based cardiac single photon emission computed tomography camera with standardized list-mode imaging and processing protocols. Patients had intermediate to high pretest probability of coronary artery disease. MBF was measured locally and at a core laboratory using commercially available software. The time a room was occupied for an MBF study was compared with that for a standard rest/stress myocardial perfusion study. Results: With motion correction, the overall correlation in MBF between core laboratory and local site was 0.93 (range, 0.87–0.97) at rest, 0.90 (range, 0.84–0.96) at stress, and 0.84 (range, 0.70–0.92) for myocardial flow reserve. The local-to-core difference in global MBF (bias -MBF ) was 5.4% (−3.8% to 14.8%; median [interquartile range]) at rest and 5.4% (−6.2% to 19.4%) at stress. Between the 5 sites, bias -MBF ranged from −1.6% to 11.0% at rest and from −1.9% to 16.3% at stress; the interquartile range in bias -MBF was between 9.3% (4.8%–14.0%) and 22.3% (−10.3% to 12.0%) at rest and between 17.0% (−11.3% to 5.6%) and 33.3% (−10.4% to 22.9%) at stress and was not significantly different between most sites. Both bias and interquartile range were like previously reported interobserver variability and less than the SD of the test-retest difference of 30%. The overall difference in myocardial flow reserve was 1.52% (−10.6% to 11.3%). There were no significant differences between with and without motion correction. The average additional acquisition time varied between sites from 44 to 79 minutes. Conclusions: The average bias -MBF and bias -MFR values were small with standard deviations substantially less than the test-retest variability. This demonstrates that MBF can be measured consistently across multiple sites and further supports that this technique can be reliably implemented. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03427749.

14 June 2021
Verified
Book
Closed access
IIIgor Iskra
Igor Iskra
DVDimitris Visvikis
Dimitris Visvikis
MKMichel Koole
Michel Koole
IAIan Armstrong
Ian Armstrong
CVChristian Vanhove
Christian Vanhove
FTFlorent Tixier
Florent Tixier

1 September 2020 in Revista Española de Medicina Nuclear e Imagen Molecular
Verified
Journal Article
Closed access
ECE. Cerudelli
E. Cerudelli
MGM. Gazzilli
M. Gazzilli
MBM. Bertoli
M. Bertoli
FBF. Bertagna
F. Bertagna
RGR. Giubbini
R. Giubbini

20 June 2021 in Hemato
Verified
Journal Article
Open access
PDF file
Domenico AlbanoDomenico Albano
Domenico Albano
FBFrancesco Bertagna
Francesco Bertagna
ECElisabetta Cerudelli
Elisabetta Cerudelli
FDFrancesco Dondi
Francesco Dondi
RGRaffaele MT Giubbini
Raffaele MT Giubbini
Our aim was to investigate the usefulness of 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the diagnosis, treatment response evaluation, and follow-up of human herpesvirus-8 (HHV-8)-associated multicentric Castleman’s disease (MCD). Fifteen patients with histologically diagnosis of HHV-8-associated MCD were retrospectively included. For all patients, a 18F-FDG PET/CT scan was performed before any treatment for diagnosis and PET/CT scans after Rituximab (4 cycles) for the evaluation of treatment response; moreover, 22 PET/CT were performed during the follow-up to check disease status. To evaluate treatment response, we applied Deauville criteria. PET/CT findings were compared with other conventional imaging (CI) findings. At diagnosis, 18F-FDG PET/CT showed an increased FDG-uptake in all cases corresponding to lymph nodes and confirming the MCD. The average SUVmax of the FDG avid lesions were 8.75, average lesion-to-liver SUVmax ratio was 3.6, and average lesion-to-blood pool SUVmax ratio was 3.9. After first-line therapy, 18F-FDG PET/CT resulted negative (Deauville score < 4) in seven patients and positive in the remaining eight (Deauville score 4–5). A negative restaging PET/CT was associated with a lower risk of relapse. During follow-up, PET/CT detected the presence of relapse or progression in 5 (23%) cases with an accuracy higher than CI. 18F-FDG PET/CT seems to be an useful tool in studying HHV-8-associated MCD both at diagnosis and during follow-up.

2 March 2022 in Journal of Nuclear Cardiology
Verified
Journal Article
Open access
PDF file
MGMaria Gazzilli
Maria Gazzilli
Domenico AlbanoDomenico Albano
Domenico Albano
SLSilvia Lucchini
Silvia Lucchini
APAlessia Peli
Alessia Peli
ECElisabetta Cerudelli
Elisabetta Cerudelli
RGRaffaele MT Giubbini
Raffaele MT Giubbini